{
    "2021-12-14": [
        [
            {
                "time": "2021-12-14",
                "original_text": "Mirikizumab Demonstrates Superiority over Placebo in Phase 3 Maintenance Study in Ulcerative Colitis, Supporting Regulatory Submissions in 2022",
                "features": {
                    "keywords": [
                        "Mirikizumab",
                        "Phase 3",
                        "Ulcerative Colitis",
                        "Regulatory Submissions"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Eli Lilly Strikes Deal With Chinese Company on New Drugs for Diabetes",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Diabetes",
                        "Deal",
                        "Chinese Company"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Who Has What? Omicron Raises Stakes for Quick Covid Sequencing",
                "features": {
                    "keywords": [
                        "Omicron",
                        "Covid",
                        "Sequencing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "PFE vs. LLY: Which Stock Should Value Investors Buy Now?",
                "features": {
                    "keywords": [
                        "PFE",
                        "LLY",
                        "Value Investors"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Foghorn (FHTX) Surges on Oncology Collaboration With Lilly",
                "features": {
                    "keywords": [
                        "Foghorn",
                        "Lilly",
                        "Oncology",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Company News for Dec 14, 2021",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-12-14",
                "original_text": "Eli Lilly and Foghorn Partner Up. Foghorn Stock Soared.",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Foghorn",
                        "Partner",
                        "Stock Soared"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}